DarioHealth

Company Overview

Snapshot

Founded in September 2011 by Dov Oppenheim, DarioHealth operates with 201–500 employees. The company has raised a total of $244.61 million across 17 funding rounds from 13 investors. In September 2025, DarioHealth announced a $17.5 million private placement of common stock.

Business overview

DarioHealth is a global digital therapeutics company focused on transforming chronic condition management, particularly for diabetes and hypertension. The company leverages AI-powered solutions to provide adaptive, personalized experiences that drive behavior change through evidence-based interventions, high-quality software, coaching, and clinically proven digital tools. Operating at the intersection of life sciences, behavioral science, and software technology, DarioHealth is expanding into new chronic conditions and geographic markets, utilizing a performance-based approach to improve user health outcomes. Its offerings include the Dario Engage Platform, Dario Blood Glucose Monitoring System, Dario Smart Diabetes Management app, and Dario Intelligence.

Strategic signal

In September 2025, DarioHealth announced a strategic review following multiple unsolicited inbound expressions of interest. This indicates significant market validation and potential for a major corporate transaction, suggesting that the company's multi-condition digital health platform is attracting considerable attention from external parties, which could lead to strategic partnerships, further investment, or even an acquisition.

Company Intelligence Q&A

What was a significant recent financial event for DarioHealth?

In September 2025, DarioHealth announced a $17.5 million private placement of common stock, priced at-the-market under Nasdaq rules.

What strategic development did DarioHealth announce in September 2025?

DarioHealth announced a strategic review in September 2025, following multiple unsolicited inbound expressions of interest, signaling potential significant corporate developments.

What new contracts did DarioHealth secure in September 2025?

In September 2025, DarioHealth secured five new employer contracts for its cardiometabolic suite, including its largest employer to date, which are expected to contribute to annual recurring revenues starting in Q3 2025.

What strategic collaboration did DarioHealth announce in October 2025?

In October 2025, DarioHealth and OneStep announced a strategic collaboration to integrate OneStep's smartphone-only, clinical-grade fall risk assessment technology into Dario's digital health multi-condition platform.

What was a key acquisition for DarioHealth in February 2024?

In February 2024, DarioHealth acquired Twill, creating a comprehensive digital health platform across prevalent chronic conditions.